REFERENCES
- Antonios, T. F., & MacGregor, G. A. (1998). Some similarities and differences between verapamil and the dihydropyridines. Journal of Hypertension, 16, 31–34.
- Ates, N., Üzüm, G., Diler, S., & Ziylan, Y. Z. (1992). The cerebrovascular permeability and epilepsy: The role of blood pressure. Neuroscience Research Communication, 10, 163–169.
- Bill, A., & Linder, A. J. (1976). Sympathetic control of cerebral blood flow in acute arte- rial hypertension. Acta Neurologica Scandinavica, 20, 91–95.
- Bronsted, H. E., & Westergaard, E. (1978). Increased vesicular transport of horseradish peroxidase across the blood-brain barrier after chemical induction of hypertension. Advances Neurology, 20, 347–348.
- Dawson, H., & Segal, M. (1995). Physiology of the CSF and blood-brain barrier. New York, London, Tokyo: CRC Press.
- De The H., Devynck, M. A., Rosenfeld, J., Pernollet, M. G., Elghozi, J. L., & Meyer, P. (1984). Plasmasodium pump inhibitor in essential hypertension and normotensive sub- jects with hypertensive heredity. Journal of Cardiovascular Pharmacology, 6, 49–54.
- Edvinsson, L., Johansson. B. B., Larsson, B., MacKenzie, E.T., Scarby, T., & Young, A. R. (1983). Calcium antagonist: Effect of cerebral blood flow and blood-brain barrier permeability in the rat. British Journal of Pharmacology, 79, 141–148.
- Ellison, M. D., Povlishock, J. T., & Hayes, R. L. (1986). Examination of the blood-to- brain transfer of α-aminoisobutyric acid and horseradish peroxidase: Regional alter-ations in blood-brain barrier function following acute hypertension. Journal of Cere- bral Blood Flow Metabolism, 6, 471–480.
- Farkos, E., De Jong, G. I., Apro, E., Keuker, J. I., & Luiten, P. G. (2001). Calcium antago- nists decrease capillary wall damage in aging hypertensive rat brain. Neurobiological Aging, 22, 299–309.
- Giacomelli, F., Wiener, J., & Spiro, D. (1970). The cellular pathology of experimental hypertension. V. Increased permeability of cerebral arterial vessels. American Journal of Pathology, 59, 133–159.
- Grabowski, M., & Johansson, B. B. (1985). Nifedipine and nimodipine: Effect on blood pressure and regional cerebral blood flow in conscious normotensive and hypertensive rats. Journal of Cardiovascular Research, 7, 1127–1133.
- Greenberg, D. A. (1987). Calcium channels and calcium channel antagonists. Annals of Neurology, 21, 317–330.
- Hansson, H. A., Johansson, B. B., & Biomstrand, C. (1975). Ultrastructural studies on cerebrovacular permeability in acute hypertension. Acta Neuropathology, 332, 187– 198.
- Hansson, H. A., & Johansson, B. B. (1980). Induction of pinocytosis in cerebral vessels by acute hypertension and by hyperosmolar solutions. Journal of Neuroscience Re- search, 5, 183–190.
- Harper, A. M., Graigen, L., & Kazda, S. (1981). Effect of the calcium antagonist nimodipine on cerebral blood flow and metabolism in the primate. Journal of Cerebral Blood Flow Metabolism, 1, 349–356.
- Haws, G. W., Gourley, J. K., & Heistad, D. D. (1983). Effects of nimodipineon cerebral blood flow. Journal of Pharmacology and Experimental Therapeutics, 225, 24–28.
- Haggendal, I. E., & Johansson, B. B. (1972). On the pathophysiology of increased cere- brovascular permeability in acute arterial hypertension in cats. Neurologica Scandinavica, 48, 265–270.
- Ijima, T., Kubota, Y., Kuroiwa, T., & Sankawa, H. (1994). Blood-brain barrier opening following transient reflex sympathetic hypertension. Acta Neurochirurgica, 60, 142– 144.
- Johansson, B. B. (1974). Blood brain barrier dysfunction in acute arterial hypertension after papaverine-induced vasodilatation. Acta Neurologica Scandinavica, 50, 573–580.
- Johansson, B. B. (1989). Hypertension and the blood-brain barrier. In E. A. Neuvelt (ed.), Implications of the blood brain barrier: Its manipulation (pp. 289–406). New York and London: Plenium Publishing Corporation.
- Johansson, B. B. (1998). Hypertension. In W. M. Pardridge (ed.), Introduction to the blood- brain barrier (pp. 427–433). London: Cambridge University Press.
- Johansson, B. B., & Linder, L. E. (1978). Reversibility of the blood-brain barrier dysfunc- tion induced by acute hypertension. Acta Neurologica Scandinavica, 57, 345–348.
- Johansson, B. B., & Martinson, L. (1979). The blood-brain barrier to albumin in awake rats in acute hypertension induced by adrenalin or anjiotensin. Acta Neurologica Scandinavica, 60, 193–197.
- Johansson, B. B., Li, C. I., Olsson, I., & Klatzo, I. (1970). The effect of acute arterial hypertension on the blood-brain barrier to protein tracers. Acta Neuropathologica, 16, 117–124.
- Kanda, K., & Flaim, S. F. (1986). Effects of nimodipine on cerebral blood flow in con- scious rat. Journal of Pharmacology and Experimental Therapeutics, 236, 41–47.
- Kazda, K., Garthoff, B., Krause, H. P., & Schlossmann, K. (1982). Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experi- ments. Drug Research, 32, 331–338.
- Kozniewska, E. (1988). Enhanced reactivity towards flunarizine in cerebrovascular bed of spontaneously hypertensive rats. Experientia, 15, 221–222.
- Kutlu, N., Vatansever, H. S., Bayazit, T. O., Ekerbicer, N., & Tan, U. (2002). Blood brain barrier in right- and left-pawed female rats assessed by a new satining method. Inter- national Journal of Neuroscience, 112, 1037–1046.
- Lehoux, S., & Plante, G. E., (1996). Antihypertensive drugs and endothelial cell function.
- Prostaglandins Leucot Essential Fatty Acids, 54, 65–70.
- Luiten, P. G., De Jong, G. I., & Schuurman, T. (1994). Cerebrovascular, neuronal and behavioral effects of long term Ca+2 channel blocked in aging normatensive and hyper- tensive rat strain. Annals of the New York Academy Sciences, 15, 431–451.
- Meyer, J. S., Waltz, A. G., & Gotoh, F. (1960). Pathogenesis of cerebral vasospasm in hypertensive encephalopathy. II. The nature of increased irritability of smooth muscle of pial arterioles in hypertension. Neurology, 10, 859–867.
- Mohamed, A. A., McCulloch, J., Mendelow, A. D., Teasdale, G. M., & Harper, A. M. (1984). Effect of calcium antagonist nimodipine on local cerebral blood flow: Rela- tionship to arterial blood pressure. Cerebral Blood Flow Metabolism, 4, 206–211.
- Mueller, S. M., & Heistad, D. O. (1980). Effects of chronic hypertension on the blood- brain barrier. Hypertension, 2, 809–812.
- Nag, S. (1984). Cerebral changes in chronic hypertension: Combined permeability and immunohistochemical studies. Acta Neuropathologica, 62, 178–184.
- Nag, S. (1988). Localization of calcium-activated adenosine-triphosphatase (Ca+2- ATPase) in intracerebral arterioles in acute hypertension. Acta Neurophathologica, 75, 547–553.
- Nag, S. (1990). Ultracytochemical localisation of Na+, K+-ATPase in cerebral endothelium in acute hypertension. Acta Neuropathologica, 80, 7–11.
- Nag, S. (1991). Protective effect of flunarizine on blood-brain barrier permeability alter- ations in acutely hypertensive rats. Stroke, 22, 1265–1269.
- Nag, S. (1997). Cerebrovascular changes in chronic hypertension. Protective effect of enalapril in rats. Stroke, 28, 1028–1034.
- Nag, S., Robertson, D. M., & Dinsdale, H. B. (1979). Quantitative estimate of pinositosis in experimenta acute hypertension. Acta Neuropathologica, 46, 107–116.
- Nag, S., Robertson, D. M., & Dinsdale, H. B. (1981). Cerebrovascular permeability in mechanically induced hypertension. Canada Journal of Neurological Sciences, 8, 215– 220.
- Nag, S., & Young, L. (1990). Cerebrovascular permeability in acute hypertension: Effect of flunarizine. Acta Neurochirugica, 51, 344–345.
- Noll, G., Wensell, R. R., Shaw, S., & Lüscher, T. F. (1998). Calcium antagonists and sympathetic nerve action: Are there differences between classes? Journal of Hyperten- sion, 16, 17–23.
- Rapaport, S. I. (1976). Brain-barrier in physiology and medicine. New York: Raven Press. Rasmussen, H. (1986). Mechanism of disease: The calcium messenger system. N English Journal of Medicine, 314, 1094–1101.
- Rössner, N., & Temple, K. (1966). Quantative bestimmung der permeabilitat der sagenonnten blut-hirn charanke fur Evans-blau (T-1824). Medical Pharmacology Experimental, 14, 162–182.
- Westergaard, E. (1977). The blood-brain barrier to horseradish peroxidase under normal and experimental conditions. Acta Neuropathologica, 34, 181–187.
- Wolman, M., Klatzo, I., Chui, E., Wilmes, F., Nishimato, K., Fujiward, K., & Spaltz, M. (1981). Evolution of dye-protein tracers in pathophysiology of the blood-brain barrier. Acta Neuropathologica, 54, 55–61.
- Ziylan, Y. Z. (1984). Pathophysiology of the opening of the blood-brain and blood-cere- brospinal fluid barrier in acute hypertension. Experimental Neurology, 84, 18–28.
- Ziylan, Y. Z., Agcioglu, G., & Gökhan, N. (1984). Effect of dexamethosone on the open- ing and reclosure time of the blood-brain barrier during acute drug-induced hyperten- sion. IRCS Medical Science, 12, 1095–1096.
- Zumkeller, M., & Dietz, H. (1996). Ultrastructural changes in the blood-brain barrier in rats after treatment with nimodipine and fluranize. A comparison. Neurosurgery Re- view, 19, 253–260.
- Zumkeller, M., Heissler, H. E., & Deitz, H. (1997). On the effect of calcium antagonists on cerebral blood flow in rats. Comparison of nimodipine and flunarizine. Neurosur- gery Review, 20, 259–268.